THE BALANCE Study: Treatment of Hyponatremia Based on Lix... | NCT00578695 | Trialant

THE BALANCE Study: Treatment of Hyponatremia Based on Lix... | NCT00578695 | Trialant

Arms/Interventions Module

Outcomes Module

Primary Outcomes

Measure	Description	Time Frame
To determine whether lixivaptan can effectively and safely produce an increase in serum sodium from Baseline in heart failure subjects with hyponatremia and volume overload. Effects on body weight and other clinical measures will be evaluated.		60 days

Ancestor Terms

ID	Term
D014883	Water-Electrolyte Imbalance
D008659	Metabolic Diseases
D009750	Nutritional and Metabolic Diseases
D012816	Signs and Symptoms
D013568	Pathological Conditions, Signs and Symptoms
D006331	Heart Diseases
D002318	Cardiovascular Diseases